Tuesday, August 20, 2013

Pew Charitable Trust Report of Sterile Compounding

Pew Recommendations:
We recommend that the Secretary of Health and Human Services direct the Commissioner of the FDA to take steps to consistently collect reliable and timely information in FDA’s existing databases on inspections and enforcement actions associated with compounded drugs, and clearly differentiate in FDA’s database, those manufacturers of FDA approved drugs that FDA inspects for compliance with good manufacturing practices from those entities compounding drugs that are not FDA-approved and that FDA does not routinely inspect.

See full report

No comments:

Post a Comment